The 14 linked references in paper E. Kropacheva S., O. Zemlyanskaya A., A. Dobrovolsky В., Е. Panchenko P., Е. Кропачева С., О. Землянская А., А. Добровольский Б., Е. Панченко П. (2018) “КЛИНИЧЕСКИЕ ФАКТОРЫ И УРОВЕНЬ АНТИКОАГУЛЯЦИИ, ОПРЕДЕЛЯЮЩИЕ РАЗВИТИЕ БЫСТРОЙ ПОТЕРИ ПОЧЕЧНОЙ ФУНКЦИИ У ПАЦИЕНТОВ, ДЛИТЕЛЬНО ПРИНИМАЮЩИХ ВАРФАРИН (5-ЛЕТНЕЕ ПРОСПЕКТИВНОЕ НАБЛЮДЕНИЕ) // CLINICAL FACTORS AND ANTICOAGULATION LEVEL THAT DETERMINE THE SUDDEN LOSS OF KIDNEY FUNCTION IN PATIENTS LONG-TAKING WARFARIN (A 5-YEAR PROSPECTIVE, OBSERVATIONAL STUDY)” / spz:neicon:aterotromboz:y:2018:i:1:p:107-121

  1. ESH / ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J, 2013, 34: 2159–2219.
  2. Beker BM, Corleto MG, Fieiras C, Musso CG. Novel acute kidney injury biomarkers: their characteristics, utility and concerns. Int Urol Nephrol, 2018 Jan 6. doi: 10.1007 / s11255-017–1781-x.
  3. Rysz J, Gluba-Brzózka A, Franczyk B et al. Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome. Int J Mol Sci, 2017 Aug 4, 18 (8). pii: E1702. doi: 10.3390 / ijms18081702.
  4. Steubl D, Block M, Herbst V et al. Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients. Medicine (Baltimore), 2016 Mar, 95 (10): e3011. doi: 10.1097 / MD.0000000000003011.
  5. Prajczer S, Heidenreich U, Pfaller W et al. Evidence for a role of uromodulin in chronic kidney disease progression. Nephrol Dial Transplant, 2010 Jun, 25 (6): 1896–1903. doi: 10.1093 / ndt / gfp748.
  6. Obermüller N, Geiger H, Weipert C, Urbschat A. Current developments in early diagnosis of acute kidney injury. Int Urol Nephrol, 2014 Jan, 46 (1): 1–7. doi: 10.1007 / s11255-013-0448–5.
  7. Кропачева Е. С., Землянская О. А., Добровольский А. Б., Панченко Е. П. Эффективность длительной терапии варфарином: влияние на частоту ишемических нарушений мозгового кровообращения и клинические предикторы их развития (результаты проспективного 10-летнего наблюдения). Атеротромбоз, 2017, 1: 145– 162. / Kropacheva ES, Zemlyanskaya OA, Dobrovolsky AB, Panchenko EP. The effectiveness of long-term warfarin therapy: impact on the frequency of ischemic disorders of cerebral circulation and the clinical predictors of their development (the results of a prospective 10-year observation). Aterotromboz, 2017, 2: 115–130.
  8. Damman K, Valente MA Voors AA et al. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated metaanalysis. Eur Heart J, 2014 Feb, 35 (7): 455–469. doi: 10.1093 / eurheartj / eht386. Epub 2013 Oct 27.
  9. Luo Y, Li X, Li J et al. Peripheral arterial disease, chronic kidney disease, and mortality: the Chinese Ankle Brachial Index Cohort Study. Vasc Med, 2010 Apr, 15 (2): 107–112. doi: 10.1177 / 1358863X09357230. Epub 2010 Feb 4.
  10. Fanola CL, Mooney D, Cowan AJ et al. Incidence of severe renal dysfunction among individuals taking warfarin and implications for non – vitamin K oral anticoagulants. Am Heart J, 2017 Feb, 184: 150–155. doi: 10.1016 / j.ahj.2016.08.017. Epub 2016 Nov 4.
  11. Beddhu S, Rocco MV, Toto R et al., SPRINT Research Group. Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial. Ann Intern Med, 2017 Sep 19, 167 (6): 375–383. doi: 10.7326 / M16–2966. Epub 2017 Sep 5.
  12. MacIsaac RJ, Jerums G, Ekinci EI. Effects of glycaemic management on diabetic kidney disease. World J Diabetes, 2017 May 15, 8 (5): 172–186. Published online 2017 May 15. doi: 10.4239 / wjd.v8.i5.172 PMCID: PMC5437616.
  13. Levey AS, Coresh J. Chronic kidney Risk Models to Predict Chronic Kidney Disease and Its Progression: A Systematic Review. Lancet, 2012, 379: 165–180. Published OnlineAugust 15, 2011. doi: 10.1016 / S0140– 6736 (11) 60178–5.
  14. Dreyer G, Hull S, Mathur R et al. Progression of chronic kidney disease in a multi-ethnic community cohort of patients with diabetes mellitus. Diabet Med, 2013 Aug, 30 (8): 956–963. doi: 10.1111 / d m e . 12197. Epub 2013 Apr 20.